|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net sales | |||
| Cost of sales | |||
| Gross profit | |||
| Selling, general, and administrative expenses | |||
| Restructuring expenses | |||
| Impairment charges | |||
| Other operating (income) expense, net | |||
| Operating income | |||
| Other expense, net | |||
| Interest expense, net | |||
| Income before taxes | |||
| Provision for taxes | |||
| Net income | |||
| Net income per share | |||
| Basic (in dollars per share) | |||
| Diluted (in dollars per share) | |||
| Weighted-average number of shares outstanding | |||
| Basic (in shares) | |||
| Diluted (in shares) |
Loading...
